Tradename | Company | Number | Date | Products |
---|---|---|---|---|
THEOPHYLLINE 0.04% AND DEXTROSE 5% IN PLASTIC CONTAINER | B. Braun Medical | N-019826 RX | 1992-08-14 | 1 products, RLD, RS |
THEOPHYLLINE 0.08% AND DEXTROSE 5% IN PLASTIC CONTAINER | B. Braun Medical | N-019826 RX | 1992-08-14 | 1 products, RLD, RS |
THEOPHYLLINE 0.16% AND DEXTROSE 5% IN PLASTIC CONTAINER | B. Braun Medical | N-019826 RX | 1992-08-14 | 1 products, RLD, RS |
THEOPHYLLINE 0.32% AND DEXTROSE 5% IN PLASTIC CONTAINER | B. Braun Medical | N-019826 RX | 1992-08-14 | 1 products, RLD, RS |
Brand Name | Status | Last Update |
---|---|---|
senophylline | unapproved drug other | 2011-08-01 |
theophylline in dextrose | New Drug Application | 2017-08-11 |
Code | Description |
---|---|
J2810 | Injection, theophylline, per 40 mg |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Chronic obstructive pulmonary disease | D029424 | EFO_0000341 | J44.9 | — | 3 | 4 | 4 | 7 | 17 |
Asthma | D001249 | EFO_0000270 | J45 | — | 3 | 6 | 6 | 1 | 15 |
Pseudohypoparathyroidism | D011547 | — | E20.1 | — | 4 | — | 1 | — | 5 |
Healthy volunteers/patients | — | — | — | 2 | — | — | 1 | — | 3 |
Bronchiectasis | D001987 | HP_0002110 | J47 | — | — | — | 2 | — | 2 |
Post-dural puncture headache | D051299 | — | — | — | — | — | 1 | 1 | 2 |
Allergic rhinitis | D065631 | — | J30.9 | — | 1 | — | 1 | — | 2 |
Kidney diseases | D007674 | EFO_0003086 | N08 | — | — | — | 1 | — | 1 |
Renal insufficiency | D051437 | HP_0000083 | N19 | — | — | — | 1 | — | 1 |
Heart block | D006327 | — | I45.89 | — | — | — | 1 | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Altitude sickness | D000532 | EFO_1000782 | T70.29 | 2 | 1 | 1 | — | — | 3 |
Acute kidney injury | D058186 | HP_0001919 | N17 | 1 | 2 | 1 | — | — | 2 |
Lung diseases | D008171 | HP_0002088 | J98.4 | — | — | 1 | — | — | 1 |
Disease progression | D018450 | — | — | — | — | 1 | — | — | 1 |
Apnea | D001049 | HP_0002104 | R06.81 | — | 1 | 1 | — | — | 1 |
Neoplasms | D009369 | — | C80 | — | — | 1 | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Covid-19 | D000086382 | — | U07.1 | — | 2 | — | — | — | 2 |
Anosmia | D000086582 | — | — | — | 2 | — | — | — | 2 |
Olfaction disorders | D000857 | HP_0000458 | R43.0 | — | 2 | — | — | — | 2 |
Promyelocytic leukemia acute | D015473 | — | C92.4 | — | 1 | — | — | — | 1 |
Myeloid leukemia acute | D015470 | — | C92.0 | 1 | 1 | — | — | — | 1 |
Ageusia | D000370 | EFO_1001758 | — | — | 1 | — | — | — | 1 |
Virus diseases | D014777 | — | B34 | — | 1 | — | — | — | 1 |
Chronic kidney failure | D007676 | EFO_0003884 | N18.6 | — | 1 | — | — | — | 1 |
Rhinosinusitis | D000096825 | — | — | — | 1 | — | — | — | 1 |
Leukemia | D007938 | — | C95 | — | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Pharmacokinetics | D010599 | — | — | 2 | — | — | — | — | 2 |
Non-small-cell lung carcinoma | D002289 | — | — | 2 | — | — | — | — | 2 |
Prostatic neoplasms | D011471 | — | C61 | 1 | — | — | — | — | 1 |
Major depressive disorder | D003865 | EFO_0003761 | F22 | 1 | — | — | — | — | 1 |
Lung neoplasms | D008175 | HP_0100526 | C34.90 | 1 | — | — | — | — | 1 |
Depression | D003863 | — | F33.9 | 1 | — | — | — | — | 1 |
Critical illness | D016638 | — | — | 1 | — | — | — | — | 1 |
Pulmonary hypertension | D006976 | EFO_0001361 | I27.20 | 1 | — | — | — | — | 1 |
Breast neoplasms | D001943 | EFO_0003869 | C50 | 1 | — | — | — | — | 1 |
Hyperuricemia | D033461 | HP_0002149 | — | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Headache disorders | D020773 | EFO_0009550 | G44 | — | — | — | — | 1 | 1 |
Central nervous system diseases | D002493 | HP_0002011 | G96.9 | — | — | — | — | 1 | 1 |
Affect | D000339 | — | — | — | — | — | — | 1 | 1 |
Skin care | D017592 | — | — | — | — | — | — | 1 | 1 |
Syncope | D013575 | HP_0012668 | G90.01 | — | — | — | — | 1 | 1 |
Drug common name | Theophylline |
INN | — |
Description | Theophylline is a dimethylxanthine having the two methyl groups located at positions 1 and 3. It is structurally similar to caffeine and is found in green and black tea. It has a role as a vasodilator agent, a bronchodilator agent, a muscle relaxant, an EC 3.1.4.* (phosphoric diester hydrolase) inhibitor, an anti-asthmatic drug, an anti-inflammatory agent, an immunomodulator, an adenosine receptor antagonist, a drug metabolite, a fungal metabolite and a human blood serum metabolite. |
Classification | Small molecule |
Drug class | — |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | Cn1c(=O)c2[nH]cnc2n(C)c1=O |